Oncology News

Ovarian cancer care costs are considerable, varying by care phase, age and geographic region, with the highest costs observed at initiation of and end-of-life care, researchers reported in the American Journal of Obstetrics and Gynecology.

False-positive mammography results discouraged women to return for further screenings, results from an observational cohort study published in the Annals of Internal Medicine showed.

The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.

The combination of pembrolizumab and chemoradiotherapy significantly improved OS for women with high-risk locally advanced cervical cancer, according to results of a randomized phase 3 trial presented at ESMO Congress.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.

In this video interview, Sara M. Tolaney, MD, MPH, highlights the increasing incidence in breast cancer.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the approvals of antibody-drug conjugates and oral targeted agents that improve outcomes among patients with breast cancer.

In this video interview, Sara M. Tolaney, MD, MPH, highlights the integration of artificial intelligence in radiologic reads to assist technicians in detecting abnormalities during breast cancer screenings.

In this video interview, Sara M. Tolaney, MD, MPH, highlights the efficacy of low-dose tamoxifen used for breast cancer prevention.